Severe asthma during childhood and adolescence: A longitudinal study

Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma. We sought to study prospectively whether well-characterized children with severe asthma ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2020-01, Vol.145 (1), p.140-146.e9
Hauptverfasser: Ross, Kristie R., Gupta, Ritika, DeBoer, Mark D., Zein, Joe, Phillips, Brenda R., Mauger, David T., Li, Chun, Myers, Ross E., Phipatanakul, Wanda, Fitzpatrick, Anne M., Ly, Ngoc P., Bacharier, Leonard B., Jackson, Daniel J., Celedón, Juan C., Larkin, Allyson, Israel, Elliot, Levy, Bruce, Fahy, John V., Castro, Mario, Bleecker, Eugene R., Meyers, Deborah, Moore, Wendy C., Wenzel, Sally E., Jarjour, Nizar N., Erzurum, Serpil C., Teague, W.Gerald, Gaston, Benjamin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 146.e9
container_issue 1
container_start_page 140
container_title Journal of allergy and clinical immunology
container_volume 145
creator Ross, Kristie R.
Gupta, Ritika
DeBoer, Mark D.
Zein, Joe
Phillips, Brenda R.
Mauger, David T.
Li, Chun
Myers, Ross E.
Phipatanakul, Wanda
Fitzpatrick, Anne M.
Ly, Ngoc P.
Bacharier, Leonard B.
Jackson, Daniel J.
Celedón, Juan C.
Larkin, Allyson
Israel, Elliot
Levy, Bruce
Fahy, John V.
Castro, Mario
Bleecker, Eugene R.
Meyers, Deborah
Moore, Wendy C.
Wenzel, Sally E.
Jarjour, Nizar N.
Erzurum, Serpil C.
Teague, W.Gerald
Gaston, Benjamin
description Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma. We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence. Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually. At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P < .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL. In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population. [Display omitted]
doi_str_mv 10.1016/j.jaci.2019.09.030
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2307133587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674919313181</els_id><sourcerecordid>2307133587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</originalsourceid><addsrcrecordid>eNp9kM9KAzEQxoMotlZfwIPs0cvWSdLNZsVLKfUPFDyo55Ams23Kdrcmu4W-jc_ik5nS6lGYYWbgm4-ZHyHXFIYUqLhbDVfauCEDWgwhBocT0qdQ5KmQLDslfYCCpiIfFT1yEcIK4sxlcU56nArGhJR9Mn3DLXpMdGiXa53Yzrt6kZilq-yyaWyi65i2qTAYrA3eJ-Pvr6qpF67trKt1lYTY7C7JWamrgFfHOiAfj9P3yXM6e316mYxnqRkBtCkyKKEwnOJcyIJSNpdCj2iZ6TkrtRYy41SO8ixWK5kokXMWe4kgGRqJfEBuD74b33x2GFq1dvGwqtI1Nl1QjENOOc9kHqXsIDW-CcFjqTberbXfKQpqj0-t1B6f2uNTEINDXLo5-nfzNdq_lV9eUfBwEGD8cuvQq2DcHox1Hk2rbOP-8_8BWSOAnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2307133587</pqid></control><display><type>article</type><title>Severe asthma during childhood and adolescence: A longitudinal study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ross, Kristie R. ; Gupta, Ritika ; DeBoer, Mark D. ; Zein, Joe ; Phillips, Brenda R. ; Mauger, David T. ; Li, Chun ; Myers, Ross E. ; Phipatanakul, Wanda ; Fitzpatrick, Anne M. ; Ly, Ngoc P. ; Bacharier, Leonard B. ; Jackson, Daniel J. ; Celedón, Juan C. ; Larkin, Allyson ; Israel, Elliot ; Levy, Bruce ; Fahy, John V. ; Castro, Mario ; Bleecker, Eugene R. ; Meyers, Deborah ; Moore, Wendy C. ; Wenzel, Sally E. ; Jarjour, Nizar N. ; Erzurum, Serpil C. ; Teague, W.Gerald ; Gaston, Benjamin</creator><creatorcontrib>Ross, Kristie R. ; Gupta, Ritika ; DeBoer, Mark D. ; Zein, Joe ; Phillips, Brenda R. ; Mauger, David T. ; Li, Chun ; Myers, Ross E. ; Phipatanakul, Wanda ; Fitzpatrick, Anne M. ; Ly, Ngoc P. ; Bacharier, Leonard B. ; Jackson, Daniel J. ; Celedón, Juan C. ; Larkin, Allyson ; Israel, Elliot ; Levy, Bruce ; Fahy, John V. ; Castro, Mario ; Bleecker, Eugene R. ; Meyers, Deborah ; Moore, Wendy C. ; Wenzel, Sally E. ; Jarjour, Nizar N. ; Erzurum, Serpil C. ; Teague, W.Gerald ; Gaston, Benjamin</creatorcontrib><description>Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma. We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence. Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually. At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P &lt; .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL. In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population. [Display omitted]</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2019.09.030</identifier><identifier>PMID: 31622688</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>adolescence ; Adolescent ; Asthma - blood ; Asthma - drug therapy ; Asthma - pathology ; Child ; eosinophilia ; Eosinophils ; Female ; Humans ; Leukocyte Count ; Longitudinal Studies ; lung function ; Male ; Prospective Studies ; Severe asthma ; Severity of Illness Index</subject><ispartof>Journal of allergy and clinical immunology, 2020-01, Vol.145 (1), p.140-146.e9</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</citedby><cites>FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</cites><orcidid>0000-0001-8794-1062</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2019.09.030$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31622688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ross, Kristie R.</creatorcontrib><creatorcontrib>Gupta, Ritika</creatorcontrib><creatorcontrib>DeBoer, Mark D.</creatorcontrib><creatorcontrib>Zein, Joe</creatorcontrib><creatorcontrib>Phillips, Brenda R.</creatorcontrib><creatorcontrib>Mauger, David T.</creatorcontrib><creatorcontrib>Li, Chun</creatorcontrib><creatorcontrib>Myers, Ross E.</creatorcontrib><creatorcontrib>Phipatanakul, Wanda</creatorcontrib><creatorcontrib>Fitzpatrick, Anne M.</creatorcontrib><creatorcontrib>Ly, Ngoc P.</creatorcontrib><creatorcontrib>Bacharier, Leonard B.</creatorcontrib><creatorcontrib>Jackson, Daniel J.</creatorcontrib><creatorcontrib>Celedón, Juan C.</creatorcontrib><creatorcontrib>Larkin, Allyson</creatorcontrib><creatorcontrib>Israel, Elliot</creatorcontrib><creatorcontrib>Levy, Bruce</creatorcontrib><creatorcontrib>Fahy, John V.</creatorcontrib><creatorcontrib>Castro, Mario</creatorcontrib><creatorcontrib>Bleecker, Eugene R.</creatorcontrib><creatorcontrib>Meyers, Deborah</creatorcontrib><creatorcontrib>Moore, Wendy C.</creatorcontrib><creatorcontrib>Wenzel, Sally E.</creatorcontrib><creatorcontrib>Jarjour, Nizar N.</creatorcontrib><creatorcontrib>Erzurum, Serpil C.</creatorcontrib><creatorcontrib>Teague, W.Gerald</creatorcontrib><creatorcontrib>Gaston, Benjamin</creatorcontrib><title>Severe asthma during childhood and adolescence: A longitudinal study</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma. We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence. Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually. At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P &lt; .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL. In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population. [Display omitted]</description><subject>adolescence</subject><subject>Adolescent</subject><subject>Asthma - blood</subject><subject>Asthma - drug therapy</subject><subject>Asthma - pathology</subject><subject>Child</subject><subject>eosinophilia</subject><subject>Eosinophils</subject><subject>Female</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Longitudinal Studies</subject><subject>lung function</subject><subject>Male</subject><subject>Prospective Studies</subject><subject>Severe asthma</subject><subject>Severity of Illness Index</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9KAzEQxoMotlZfwIPs0cvWSdLNZsVLKfUPFDyo55Ams23Kdrcmu4W-jc_ik5nS6lGYYWbgm4-ZHyHXFIYUqLhbDVfauCEDWgwhBocT0qdQ5KmQLDslfYCCpiIfFT1yEcIK4sxlcU56nArGhJR9Mn3DLXpMdGiXa53Yzrt6kZilq-yyaWyi65i2qTAYrA3eJ-Pvr6qpF67trKt1lYTY7C7JWamrgFfHOiAfj9P3yXM6e316mYxnqRkBtCkyKKEwnOJcyIJSNpdCj2iZ6TkrtRYy41SO8ixWK5kokXMWe4kgGRqJfEBuD74b33x2GFq1dvGwqtI1Nl1QjENOOc9kHqXsIDW-CcFjqTberbXfKQpqj0-t1B6f2uNTEINDXLo5-nfzNdq_lV9eUfBwEGD8cuvQq2DcHox1Hk2rbOP-8_8BWSOAnQ</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Ross, Kristie R.</creator><creator>Gupta, Ritika</creator><creator>DeBoer, Mark D.</creator><creator>Zein, Joe</creator><creator>Phillips, Brenda R.</creator><creator>Mauger, David T.</creator><creator>Li, Chun</creator><creator>Myers, Ross E.</creator><creator>Phipatanakul, Wanda</creator><creator>Fitzpatrick, Anne M.</creator><creator>Ly, Ngoc P.</creator><creator>Bacharier, Leonard B.</creator><creator>Jackson, Daniel J.</creator><creator>Celedón, Juan C.</creator><creator>Larkin, Allyson</creator><creator>Israel, Elliot</creator><creator>Levy, Bruce</creator><creator>Fahy, John V.</creator><creator>Castro, Mario</creator><creator>Bleecker, Eugene R.</creator><creator>Meyers, Deborah</creator><creator>Moore, Wendy C.</creator><creator>Wenzel, Sally E.</creator><creator>Jarjour, Nizar N.</creator><creator>Erzurum, Serpil C.</creator><creator>Teague, W.Gerald</creator><creator>Gaston, Benjamin</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8794-1062</orcidid></search><sort><creationdate>202001</creationdate><title>Severe asthma during childhood and adolescence: A longitudinal study</title><author>Ross, Kristie R. ; Gupta, Ritika ; DeBoer, Mark D. ; Zein, Joe ; Phillips, Brenda R. ; Mauger, David T. ; Li, Chun ; Myers, Ross E. ; Phipatanakul, Wanda ; Fitzpatrick, Anne M. ; Ly, Ngoc P. ; Bacharier, Leonard B. ; Jackson, Daniel J. ; Celedón, Juan C. ; Larkin, Allyson ; Israel, Elliot ; Levy, Bruce ; Fahy, John V. ; Castro, Mario ; Bleecker, Eugene R. ; Meyers, Deborah ; Moore, Wendy C. ; Wenzel, Sally E. ; Jarjour, Nizar N. ; Erzurum, Serpil C. ; Teague, W.Gerald ; Gaston, Benjamin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>adolescence</topic><topic>Adolescent</topic><topic>Asthma - blood</topic><topic>Asthma - drug therapy</topic><topic>Asthma - pathology</topic><topic>Child</topic><topic>eosinophilia</topic><topic>Eosinophils</topic><topic>Female</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Longitudinal Studies</topic><topic>lung function</topic><topic>Male</topic><topic>Prospective Studies</topic><topic>Severe asthma</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ross, Kristie R.</creatorcontrib><creatorcontrib>Gupta, Ritika</creatorcontrib><creatorcontrib>DeBoer, Mark D.</creatorcontrib><creatorcontrib>Zein, Joe</creatorcontrib><creatorcontrib>Phillips, Brenda R.</creatorcontrib><creatorcontrib>Mauger, David T.</creatorcontrib><creatorcontrib>Li, Chun</creatorcontrib><creatorcontrib>Myers, Ross E.</creatorcontrib><creatorcontrib>Phipatanakul, Wanda</creatorcontrib><creatorcontrib>Fitzpatrick, Anne M.</creatorcontrib><creatorcontrib>Ly, Ngoc P.</creatorcontrib><creatorcontrib>Bacharier, Leonard B.</creatorcontrib><creatorcontrib>Jackson, Daniel J.</creatorcontrib><creatorcontrib>Celedón, Juan C.</creatorcontrib><creatorcontrib>Larkin, Allyson</creatorcontrib><creatorcontrib>Israel, Elliot</creatorcontrib><creatorcontrib>Levy, Bruce</creatorcontrib><creatorcontrib>Fahy, John V.</creatorcontrib><creatorcontrib>Castro, Mario</creatorcontrib><creatorcontrib>Bleecker, Eugene R.</creatorcontrib><creatorcontrib>Meyers, Deborah</creatorcontrib><creatorcontrib>Moore, Wendy C.</creatorcontrib><creatorcontrib>Wenzel, Sally E.</creatorcontrib><creatorcontrib>Jarjour, Nizar N.</creatorcontrib><creatorcontrib>Erzurum, Serpil C.</creatorcontrib><creatorcontrib>Teague, W.Gerald</creatorcontrib><creatorcontrib>Gaston, Benjamin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ross, Kristie R.</au><au>Gupta, Ritika</au><au>DeBoer, Mark D.</au><au>Zein, Joe</au><au>Phillips, Brenda R.</au><au>Mauger, David T.</au><au>Li, Chun</au><au>Myers, Ross E.</au><au>Phipatanakul, Wanda</au><au>Fitzpatrick, Anne M.</au><au>Ly, Ngoc P.</au><au>Bacharier, Leonard B.</au><au>Jackson, Daniel J.</au><au>Celedón, Juan C.</au><au>Larkin, Allyson</au><au>Israel, Elliot</au><au>Levy, Bruce</au><au>Fahy, John V.</au><au>Castro, Mario</au><au>Bleecker, Eugene R.</au><au>Meyers, Deborah</au><au>Moore, Wendy C.</au><au>Wenzel, Sally E.</au><au>Jarjour, Nizar N.</au><au>Erzurum, Serpil C.</au><au>Teague, W.Gerald</au><au>Gaston, Benjamin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe asthma during childhood and adolescence: A longitudinal study</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2020-01</date><risdate>2020</risdate><volume>145</volume><issue>1</issue><spage>140</spage><epage>146.e9</epage><pages>140-146.e9</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma. We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence. Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually. At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P &lt; .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL. In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31622688</pmid><doi>10.1016/j.jaci.2019.09.030</doi><orcidid>https://orcid.org/0000-0001-8794-1062</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2020-01, Vol.145 (1), p.140-146.e9
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_2307133587
source MEDLINE; Elsevier ScienceDirect Journals
subjects adolescence
Adolescent
Asthma - blood
Asthma - drug therapy
Asthma - pathology
Child
eosinophilia
Eosinophils
Female
Humans
Leukocyte Count
Longitudinal Studies
lung function
Male
Prospective Studies
Severe asthma
Severity of Illness Index
title Severe asthma during childhood and adolescence: A longitudinal study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A27%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20asthma%20during%20childhood%20and%20adolescence:%20A%C2%A0longitudinal%20study&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Ross,%20Kristie%20R.&rft.date=2020-01&rft.volume=145&rft.issue=1&rft.spage=140&rft.epage=146.e9&rft.pages=140-146.e9&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2019.09.030&rft_dat=%3Cproquest_cross%3E2307133587%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2307133587&rft_id=info:pmid/31622688&rft_els_id=S0091674919313181&rfr_iscdi=true